BENZYL BENZOATESolvent/co-solvent for pharmaceutical injectable formulations. It has a strong control on all possible impurities along with ICH Q3D compliance for R&D to commercial manufacturing.Benefits:It maintains low level of endotoxins with the bioburden limits- BET/MLTControlled metallic impurities Developed for solid and semi-solid dosage forms
BENZYL BENZOATE USP/PH.EUR/BP PARENTEX PLUSExcipient developed for injectable formulations. It functions as a preservative/antimicrobial. Benefits:Maintains a low level of endotoxins with the bioburden limits (BET/MLT etc)
BUTYL ALCOHOL (N-BUTYL ALCOHOL) USP-NFExcipiteent having possible use in pharmaceutical applications.
BUTYLATED HYDROXYANISOLEAntioxidant for pharmaceutical applications such as solid and semi-solid dosage forms.Benefits:DMF filed excipient - CDE # F20200000188All peak positions are within 5cm-1cm of those determined for 3-tert-Butyl-4-hydroxyanisole standard